RUA Life Sciences plc / Fundamentals

    Income statement

    Net revenue
    €5.51M
    Cost of goods sold
    €1.65M
    Gross profit
    €3.86M
    SG&A expenses
    €6.54M
    R&D expenses
    €2.27M
    EBITDA
    -€1.97M
    D&A
    €835.35K
    EBIT
    -€4.08M
    Interest expenses
    €140.38K
    EBT
    -€2.95M
    Tax expenses
    -€1.04M
    Net income
    -€1.91M

    Cash flow statement

    Net deferred tax
    -€231.27K
    Non-cash items
    -€965.37K
    Changes in working capital
    -€154.18K
    Operating cash flow
    -€2.61M
    Capex
    €512.02K
    Other investing cash flow
    -€56.38K
    Net investing cash flow
    -€283.05K
    Total cash dividends paid
    €0.00
    Issuance of common stock
    €4.57M
    Debt repayment
    -€162.24K
    Other financing cash flow
    €4.59M
    Net financing cash flow
    €4.43M
    Foreign exchange effects
    -€18.41K
    Net change in cash
    €1.64M
    Cash at end of period
    €4.35M
    Free cash flow
    -€2.10M

    Balance sheet

    Cash and cash equivalents
    €4.35M
    Cash and short-term investments
    €4.35M
    Total receivables
    €1.17M
    Inventory
    €1.28M
    Other current assets
    €0.00
    Total current assets
    €6.80M
    Property, plant & equipment
    €3.48M
    Goodwill
    €346.34K
    Intangible assets
    €654.70K
    Long-term investments
    €0.00
    Other non-current assets
    €0.00
    Total non-current assets
    €4.49M
    Total assets
    €11.28M
    Accounts payable
    €132.32K
    Short-term debt
    €471.75K
    Other current liabilities
    €446.44K
    Total current liabilities
    €1.05M
    Long-term debt
    €881.37K
    Deferred tax liabilities
    €79.39K
    Other non-current liabilities
    €82.84K
    Total non-current liabilities
    €1.04M
    Total liabilities
    €2.09M
    Common stock
    €3.57M
    Retained earnings
    -€22.27M
    Other equity
    €11.97M
    Total equity
    €9.19M
    Total liabilities and shareholders' equity
    €11.28M

    Company information

    Market capitalization
    €8.99M
    Employees
    40
    Enterprise Value
    €4.74M

    Company ratios

    Gross margin
    70.0% Much better than peer group: 37.0%
    EBITDA margin
    -35.8% Much worse than peer group: 6.6%
    EBIT margin
    -74.1% Much worse than peer group: 2.4%
    EBT margin
    -53.5% Much worse than peer group: -12.0%
    Net margin
    -34.7% Much worse than peer group: -14.3%
    ROE
    -20.8% Much better than peer group: -366.2%
    ROA
    -17.0% Much better than peer group: -300.7%
    Asset turnover
    48.8% Much better than peer group: 18.2%
    FCF margin
    -56.7% Much worse than peer group: -3.7%
    FCF yield
    -34.8%
    Efficiency ratio
    135.8%
    Net sales per employee
    €137.79K
    Net income per employee
    -€47.87K

    Notifications